DECR2 and neoplasm: We further evaluated whether TEX11-specific siRNA can reduce in vivo tumor growth of cisplatin-resistant TGCT cells using a TGCT-PDC-R-derived xenograft model of NOD/SCID mice treated with cisplatin.